Alon Schaffer Selected Research

Alon Schaffer Research Topics

Disease

25	Coronary Artery Disease (Coronary Atherosclerosis) 02/2017 - 01/2010
22	Myocardial Infarction 08/2020 - 05/2013
19	Thrombosis (Thrombus) 08/2020 - 07/2013
15	Acute Coronary Syndrome 08/2020 - 03/2014
15	Hypertension (High Blood Pressure) 02/2016 - 05/2011
13	Renal Insufficiency (Renal Failure) 08/2016 - 05/2014
10	Hemorrhage 01/2018 - 04/2014
7	Diabetes Mellitus 07/2016 - 05/2014
5	Stroke (Strokes) 05/2016 - 04/2014
5	Hypercholesterolemia 01/2016 - 05/2014
4	ST Elevation Myocardial Infarction 01/2018 - 05/2015
4	Atherosclerosis 01/2016 - 05/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 02/2017 - 10/2014
2	Coronary Stenosis (Coronary Artery Stenosis) 08/2020 - 01/2015
2	Hypersensitivity (Allergy) 05/2016 - 07/2013
2	Coronary Disease (Coronary Heart Disease) 02/2015 - 01/2015
2	Stable Angina 01/2015 - 04/2014
2	Heart Valve Diseases (Valvular Heart Disease) 11/2010 - 01/2010
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 11/2010 - 01/2010
1	Cardiogenic Shock 01/2020
1	Neglected Diseases 01/2020
1	Infarction (Infarctions) 12/2016
1	Ischemic Stroke 12/2016
1	Left Ventricular Dysfunction 05/2016
1	Chronic Renal Insufficiency 05/2016
1	Necrosis 05/2015
1	Hyperglycemia 05/2015
1	Pathologic Constriction (Stenosis) 02/2015
1	Dyslipidemias (Dyslipidemia) 02/2015
1	Vitamin D Deficiency 07/2014
1	Hyperuricemia 05/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2014
1	Ischemia 04/2014
1	Hyperkalemia 11/2013
1	Anaphylaxis (Anaphylactic Shock) 07/2013
1	Chronic Kidney Failure (Chronic Renal Failure) 05/2011
1	Carotid Artery Diseases 05/2011

Drug/Important Bio-Agent (IBA)

16	DiureticsIBA 05/2016 - 01/2010
12	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2017 - 01/2010
10	Clopidogrel (Plavix)FDA Link 01/2018 - 05/2011
9	NitratesIBA 02/2017 - 05/2011
9	TicagrelorIBA 12/2016 - 04/2014
8	CalciumIBA 05/2016 - 04/2014
7	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2016 - 01/2015
7	CreatinineIBA 08/2016 - 05/2014
5	HDL CholesterolIBA 08/2016 - 05/2014
5	Angiotensin Receptor AntagonistsIBA 05/2016 - 07/2014
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2016 - 07/2013
5	Uric Acid (Urate)IBA 01/2016 - 05/2014
4	bivalirudin (Angiomax)FDA Link 10/2017 - 05/2015
4	Vitamin D FDA LinkGeneric 02/2017 - 07/2014
4	Fibrinogen (Factor I)FDA Link 05/2016 - 05/2011
4	HomocysteineIBA 01/2016 - 08/2014
4	Triglycerides (Triacylglycerol)IBA 02/2015 - 05/2014
3	Glycoproteins (Glycoprotein)IBA 10/2017 - 01/2015
3	Adenosine Diphosphate (ADP)IBA 08/2016 - 07/2013
3	Glucose (Dextrose)FDA LinkGeneric 07/2016 - 07/2014
3	HDL LipoproteinsIBA 07/2015 - 09/2014
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 05/2015 - 07/2014
3	CholesterolIBA 02/2015 - 08/2014
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 08/2014 - 05/2014
2	Heparin (Liquaemin)FDA LinkGeneric 10/2017 - 08/2016
2	LipidsIBA 02/2017 - 07/2015
2	omega-Chloroacetophenone (Mace)IBA 01/2017 - 10/2014
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2016 - 02/2015
2	C-Reactive ProteinIBA 02/2015 - 09/2014
2	Troponin IIBA 01/2015 - 05/2014
2	Integrin beta3 (GPIIIa)IBA 01/2015 - 01/2015
2	MB Form Creatine KinaseIBA 01/2015 - 05/2014
2	Platelet Membrane Glycoprotein IIbIBA 01/2015 - 06/2013
2	Prasugrel Hydrochloride FDA Link 10/2014 - 04/2014
2	LDL Lipoproteins (beta Lipoproteins)IBA 09/2014 - 08/2014
2	Indicators and Reagents (Reagents)IBA 11/2010 - 01/2010
1	PolymersIBA 08/2020
1	Sirolimus (Rapamycin)FDA Link 08/2020
1	Antihypertensive Agents (Antihypertensives)IBA 02/2017
1	AntithrombinsIBA 12/2016
1	Cholecalciferol (Vitamin D3)FDA Link 08/2016
1	Parathyroid Hormone (Parathormone)IBA 08/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2016
1	AcidsIBA 10/2015
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 10/2015
1	Fibrinogen ReceptorsIBA 01/2015
1	hemoglobin P (Hb P)IBA 09/2014
1	oxidized low density lipoproteinIBA 08/2014
1	cangrelorIBA 04/2014

Therapy/Procedure

19	Percutaneous Coronary Intervention 08/2020 - 05/2013
17	Therapeutics 02/2017 - 07/2013
14	Stents 08/2020 - 07/2013
4	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2020 - 05/2014
3	Drug-Eluting Stents 08/2020 - 09/2014
3	Glycemic Control 05/2016 - 05/2014
1	Secondary Prevention 01/2018
1	Anticoagulation Reversal 02/2015
1	Thrombectomy 09/2014
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 11/2013